Literature DB >> 21658694

Concordance between chart review and structured interview assessments of schizophrenic symptoms.

Ayman H Fanous1, Richard L Amdur, Francis A O'Neill, Dermot Walsh, Kenneth S Kendler.   

Abstract

BACKGROUND: It is unclear whether direct structured interviews are able to capture the full range of psychopathology in schizophrenia, as is required in diagnostic assessments or clinical ratings. We examined agreement between symptom ratings derived from direct patient interviews and from review of casenotes.
METHODS: The study sample comprised 1021 schizophrenic subjects collected as part of the Irish Case-Control Study of Schizophrenia. Diagnostic interviews used a modified version of the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Symptoms were rated by the interviewer. In addition, the Casenote Rating Scale was used to rate symptoms based on medical record information. For each negative and positive symptom, we calculated the Pearson correlation between the interview and the casenote rating. Using the mean of the interview and casenote rating for each symptom, exploratory factor analysis using Varimax rotation was performed.
RESULTS: Three factors were extracted in factor analysis: positive, negative, and Schneiderian symptoms. The highest correlations between interview and casenote ratings were for negative symptoms, in which all symptoms were significantly correlated. Positive and Schneiderian symptoms were significantly correlated with the exception of thought insertion, thought withdrawal, voices speaking in sentences, and somatic hallucinations. Significant correlations were generally moderate (0.2-0.55).
CONCLUSION: Most schizophrenic symptoms, especially negative symptoms, can be assessed by direct interviews as the sole source of information with moderate reliability. However, the presence of some Schneiderian and possibly less prevalent positive symptoms may be difficult to determine without a review of records, which may include longitudinal observations and information from multiple observers. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21658694      PMCID: PMC3752589          DOI: 10.1016/j.comppsych.2011.04.006

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  18 in total

Review 1.  How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment.

Authors:  V Peralta; M J Cuesta
Journal:  Schizophr Res       Date:  2001-04-30       Impact factor: 4.939

2.  Working memory constrains abstraction in schizophrenia.

Authors:  D C Glahn; T D Cannon; R E Gur; J D Ragland; R C Gur
Journal:  Biol Psychiatry       Date:  2000-01-01       Impact factor: 13.382

Review 3.  The positive-negative distinction in schizophrenia. Review of natural history validators.

Authors:  T H McGlashan; W S Fenton
Journal:  Arch Gen Psychiatry       Date:  1992-01

4.  Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features.

Authors:  S Pini; G B Cassano; L Dell'Osso; X F Amador
Journal:  Am J Psychiatry       Date:  2001-01       Impact factor: 18.112

5.  Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.

Authors:  V Peralta; M J Cuesta; A Martinez-Larrea; J F Serrano
Journal:  Am J Psychiatry       Date:  2000-09       Impact factor: 18.112

6.  Factor structure and familiality of first-rank symptoms in sibling pairs with schizophrenia and schizoaffective disorder.

Authors:  J Loftus; L E Delisi; T J Crow
Journal:  Br J Psychiatry       Date:  2000-07       Impact factor: 9.319

7.  The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives.

Authors:  K S Kendler; M McGuire; A M Gruenberg; A O'Hare; M Spellman; D Walsh
Journal:  Arch Gen Psychiatry       Date:  1993-07

8.  Validity of symptom assessment in psychotic disorders: information variance across different sources of history.

Authors:  Beng-Choon Ho; Michael Flaum; William Hubbard; Stephan Arndt; Nancy C Andreasen
Journal:  Schizophr Res       Date:  2004-06-01       Impact factor: 4.939

9.  Dysbindin genotype and negative symptoms in schizophrenia.

Authors:  Pamela DeRosse; Birgit Funke; Katherine E Burdick; Todd Lencz; Jenny M Ekholm; John M Kane; Raju Kucherlapati; Anil K Malhotra
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

10.  The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results.

Authors:  D L Braff; R Heaton; J Kuck; M Cullum; J Moranville; I Grant; S Zisook
Journal:  Arch Gen Psychiatry       Date:  1991-10
View more
  4 in total

Review 1.  First rank symptoms for schizophrenia.

Authors:  Karla Soares-Weiser; Nicola Maayan; Hanna Bergman; Clare Davenport; Amanda J Kirkham; Sarah Grabowski; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-01-25

2.  Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes.

Authors:  Alexis C Edwards; Tim B Bigdeli; Anna R Docherty; Silviu Bacanu; Donghyung Lee; Teresa R de Candia; Arden Moscati; Dawn L Thiselton; Brion S Maher; Brandon K Wormley; Dermot Walsh; Francis A O'Neill; Kenneth S Kendler; Brien P Riley; Ayman H Fanous
Journal:  Schizophr Bull       Date:  2015-08-27       Impact factor: 9.306

3.  Low correlation between self-report and medical record documentation of urinary tract infection symptoms.

Authors:  Jose F Echaiz; Candice Cass; Jeffrey P Henderson; Hilary M Babcock; Jonas Marschall
Journal:  Am J Infect Control       Date:  2015-06-16       Impact factor: 2.918

4.  Resemblance of symptoms for major depression assessed at interview versus from hospital record review.

Authors:  Ying Chen; Haimin Li; Yihan Li; Dong Xie; Zhiyang Wang; Fuzhong Yang; Yuan Shen; Sulin Ni; Yan Wei; Yanhua Liu; Lanfen Liu; Chengge Gao; Jun Liu; Lijuan Yan; Gang Wang; Keqing Li; Qiang He; Tiebang Liu; Jinbei Zhang; Yan Ren; Qunli Du; Jing Tian; Honghui Chen; Yanfang Luo; Fengzhi Zhang; Guangwei Sun; Chunjie Shan; Xueyi Wang; Yutang Zhang; Xiaoqin Weng; Yunchun Chen; Zhen Kang; Jing Guan; Yiping Chen; Shenxun Shi; Kenneth S Kendler; Jonathan Flint; Hong Deng
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.